Impact of perinatal practices for early-onset group b streptococcal disease prevention

Pediatric Infectious Disease Journal

Volumn 32, Issue 7, 2013, Pages 265-271

  Berardi, Alberto ^a   Lugli, Licia ^a   Rossi, Cecilia ^a   Guidotti, Isotta ^a   Lanari, Marcello ^b   Creti, Roberta ^c   Perrone, Enrica ^d   Biasini, Augusto ^e   Sandri, Fabrizio ^f   Volta, Alessandro ^g   China, Mariachiara ^h   Sabatini, Laura ⁱ   Baldassarri, Lucilla ^c   Vagnarelli, Federica ^j   Ferrari, Fabrizio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b DEA Ospedale SM Della Scaletta   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d AUSL Modena   (Italy)

^e OSPEDALE M BUFALINI   (Italy)

^f MAGGIORE HOSPITAL   (Italy)

^g Ospedale Franchini   (Italy)

^h Osp Infermi   (Italy)

ⁱ SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^j S MARIA NUOVA HOSPITAL   (Italy)

more..

Author keywords

Group B streptococcus; Intrapartum prophylaxis; Neonatal management; Newborn; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; COHORT ANALYSIS; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; OBSERVATIONAL STUDY; PERINATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING;

COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ITALY; MALE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84883206000     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828b0884     Document Type: Article

References (31)

1. Edwards MS, Baker CJ, Remington JS, Klein JO. Group B Streptococcal infections. In: Infectious Diseases of the Fetus and Newborn Infant. 20055th ed Philadelphia Saunders:1091-1156
2. Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22
3. Verani JR, McGee L, Schrag SJ Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36
4. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103:e77
5. Berardi A, Lugli L, Baronciani D, et al. GBS Prevention Working Group of Emilia-Romagna. Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach. Pediatr Infect Dis J. 2010;29:115-121
6. CDC. Trends in perinatal group B streptococcal disease-United States, 2000-2006 MMWR. 2009;58:109-12
7. Phares CR, Lynfield R, Farley MM, et al. Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299:2056-2065
8. Centers. for Disease Control and Prevention. 2011. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, provisional-2010. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/gbs10.pdf. Accessed March 7, 2013.
9. Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol. 2006;108:1254-1265
10. Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol. 2010;37:421-438
11. Royal. College of Obstetricians and Gynaecologists. Guidelines. Prevention of early onset neonatal group B streptococcal disease. Guideline N°; 36. 2003, 1-10. Available at: http://www.rcog.org.uk/resources/Public/pdf/GroupB_strep_no36.pdf. Accessed March 7, 2013.
12. Hashavya S, Benenson S, Ergaz-Shaltiel Z, et al. The use of blood counts and blood cultures to screen neonates born to partially treated group B Streptococcus-carrier mothers for early-onset sepsis: is it justified? Pediatr Infect Dis J. 2011;30:840-843
13. Campbell N, Eddy A, Darlow B, et al. New Zealand GBS Consensus Working Party. The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party. N Z Med J. 2004;117:U1023
14. Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants<=2000 grams at birth: A population-based study. Pediatrics. 2000;106(2 Pt 1):256-263
15. Polin RA Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006-1015
16. Berardi A, Lugli L, Baronciani D, et al. GBS Prevention Working Group of Emilia-Romagna. Group B streptococcal infections in a northern region of Italy. Pediatrics. 2007;120:e487-e493
17. Berardi A, Rossi C, Lugli L, et al. Group B streptococcus late-onset disease: 2003-2010. Pediatrics. 2013;131:e361-e368
18. Berardi A, Di Fazzio G, Gavioli S, et al. GBS Prevention Working Group, Emilia-Romagna. Universal antenatal screening for group B streptococcus in Emilia-Romagna. J Med Screen. 2011;18:60-64
19. Haque KN. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med. 2005;6(suppl 3):S45-S49
20. Sarff LD, Platt LH, McCracken GH Jr. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr. 1976;88:473-477
21. Moses LM, Heath PT, Wilkinson AR, et al. Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child Fetal Neonatal Ed. 1998;79:F148-F149
22. Hofer N, Müller W, Resch B. Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med. 2011;49:297-302
23. Chiesa C, Natale F, Pascone R, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011;412:1053-1059
24. Berardi A, Lugli L, Rossi C, et al. Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease. J Matern Fetal Neonatal Med. 2011;24:1221-1224
25. Goins WP, Talbot TR, Schaffner W, et al. Adherence to perinatal group B streptococcal prevention guidelines. Obstet Gynecol. 2010;115:1217-1224
26. Davis RL, Hasselquist MB, Cardenas V, et al. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol. 2001;184:603-610
27. Berardi A, Rossi C, Biasini A, et al. Efficacy of intrapartum chemoprophylaxis less than 4 hours duration. J Matern Fetal Neonatal Med. 2011;24:619-625
28. Hsu KK, Pelton SI, Shapiro DS. Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis. 2003;45:23-27
29. Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J. 2003;22:430-434
30. Glasgow TS, Speakman M, Firth S, et al. Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers. Paediatr Perinat Epidemiol. 2007;21:338-346
31. Platt R, Adelson-Mitty J, Weissman L, et al. Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease. Pediatr Infect Dis J. 1999;18:529-533